YOUR BUSINESS AUTHORITY
Springfield, MO
St. Louis biotech startup Arch Oncology raised $105 million in a funding round.
The round was led by Eventide Asset Management, Cowen Healthcare Investments and 3x5 Partners.
Arch Oncology is developing biologic therapies to treat patients with tumors and hematologic malignancies.
Read more from the St. Louis Business Journal.
For 25 years, Springfield Business Journal has honored local women for their professional and civic accomplishments and contributions.
Updated: Jason Gage to resign as city manager
Downtown business owners pen letter critical of Route 66 Festival
Construction to start this month on restaurant at historic mill site
Apartments planned at century-old building in downtown Springfield
American Airlines adds seasonal Miami flight at Springfield airport